ArticleBMJ neurology open2026

Two phase 1 randomised studies investigating the safety and pharmacokinetics of bepranemab in healthy participants of different ethnicities.

Tim J Buchanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.